Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
57 Leser
Artikel bewerten:
(0)

Global High Throughput Screening (HTS) Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Danaher, PerkinElmer, Sigma-Aldrich and Thermo Fisher

DUBLIN, Oct. 14, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global High Throughput Screening (HTS) Market 2014-2018" report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769

High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other research applications.

The high sensitivity, high speed, and easy to use supports the adoption of HTS in research and drug discovery to identify enzymes, ligands for receptors, ion-channels, or other pharmacological targets of interest. HTS is a crucial step in drug discovery for various applications such as assay development, target identification, and primary screening.

The analysts forecast the Global HTS market to grow at a CAGR of 7.85 percent over the period 2013-2018.

This report covers the present scenario and the growth prospects of the Global HTS market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of instruments, consumables, and services used for HTS. It also includes the technologies used for HTS such as cell-based assays, LOC, uHTS, label-free technology, and bioinformatics.

The report, the Global High Throughput Screening Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global HTS market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

One of the major trends emerging in the market is the improved automation and miniaturization of HTS techniques, which helps reduce the consumption of reagents and other chemical compounds in the tests.

According to the report, one of the major drivers in the market is advances in HTS technology. The use of HTS technology and products has increased because of automation, improved accuracy, sensitivity, and robotics. Automated robotics reduces the manual handling of the samples, which helps reduce the errors.

Further, the report states that one of the major challenges in the market is the intense competition among the vendors. There are many big, medium, and small companies in the market that provide high-end instruments and other products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Market Segmentation by Application

08. Market Segmentation by Technology

09. Market Segmentation by Product

10. Geographical Segmentation

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

19. Key Vendor Analysis

Companies Mentioned:

  • Agilent Technologies
  • Aurora Biomed
  • Axxam
  • BMG LABTECH
  • Becton
  • Bio-Rad Laboratories
  • BioFocus DPI
  • BioTek Instruments
  • Brooks Automation
  • Charles River LaboratoriesInternational
  • Corning
  • Danaher
  • Dickinson and Company
  • DiscoveRx
  • Dynamic Devices
  • Evotec
  • F. Hoffmann-La Roche
  • Genedata
  • Intellicyt
  • Luminex
  • PerkinElmer
  • Sigma-Aldrich
  • Tecan Group
  • Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/sfs9c2/global_high

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

© 2014 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.